|
|
| | L-Tyrosine, 3-hydroxy-, monosodium salt (9CI) Basic information |
| | L-Tyrosine, 3-hydroxy-, monosodium salt (9CI) Chemical Properties |
| | L-Tyrosine, 3-hydroxy-, monosodium salt (9CI) Usage And Synthesis |
| Description | Levodopa is the naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. | | in vitro | SH-SY5Y cells were treated with CA (carnosic acid) for 18 h, and then co-treated with 400 μM L-dopa for the indicated time points. The results showed that pretreatment of CA attenuated the cell death and nuclear condensation induced by L-dopa. In conclusion, CA ameliorates the development of LID via regulating the D1R signaling and prevents L-dopa-induced apoptotic cell death through modulating the ERK1/2-c-Jun and inducing the parkin._x000D_
_x000D_
Reference: Front Pharmacol. 2021 Aug 9;12:703894. https://pubmed.ncbi.nlm.nih.gov/34434108/ | | in vivo | These results confirm previous findings that rotenone-induced motor and non-motor problems were alleviated by the Active diet (AD). Levodopa showed an additive beneficial effect on rotarod performance in rotenone-treated mice fed with the AD._x000D_
_x000D_
Reference: Front Aging Neurosci. 2018 Aug 3;10:237. https://pubmed.ncbi.nlm.nih.gov/30127735/ | | target | L-DOPA (Levodopa) sodium is an orally active metabolic precursor of neurotransmitters dopamine. |
| | L-Tyrosine, 3-hydroxy-, monosodium salt (9CI) Preparation Products And Raw materials |
|